Microsaic Systems - Annual Financial Report
29/06/2023 16:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230629:nRSc4384Ea&default-theme=true
RNS Number : 4384E Microsaic Systems plc 29 June 2023
29 June 2023
Microsaic Systems plc
("Microsaic" or the "Company")
FY22 Annual Report and Accounts
Further to the Company's announcement on 26 June 2023 (the "Prior
Announcement"), the Board of Microsaic (AIM: MSYS) now confirms that the
Company's annual report and accounts for the year ended 31 December 2022
("FY22") will not be published by 30 June 2023, being the deadline for
publication under the AIM Rules for Companies. Consequently, the Company's
shares will be suspended from trading on AIM with effect from 3 July 2023,
pending publication of the FY22 annual report and accounts.
The Board noted in the Prior Announcement that, as of 31 May 2023, Microsaic
had £0.65m in cash and on deposit, with no bank borrowings. The Company also
stated that it continues to meet its obligations as they fall due. In light of
the challenges associated with making further recovery of the outstanding
debtor balance from DeepVerge plc, and that the conversion of its growing
pipeline and the speed and scale of revenue generation are uncertain, the
Prior Announcement noted that it was likely that Microsaic will need to raise
further working capital during Q3 2023.
The Company confirms that it is working to that end and intends to conclude a
fundraising within that period, and to seek reinstatement of its shares to
trading on AIM shortly aftewards, subject also to having published the FY22
report and accounts on a going concern basis. Such fundraising is likely to be
subject to shareholder approval to issue and allot new shares.
Further announcements will be made as appropriate.
Enquiries:
Microsaic Systems plc +44 (0)1483 751 577
Gerry Brandon (Executive Chairman)
N+1 Singer (Nominated Adviser & Joint Broker) +44 (0)20 7496 3000
Aubrey Powell / George Tzimas (Investment Banking)
Turner Pope Investments (TPI) Limited (Joint Broker) +44 (0) 20 3657 0050
Andy Thacker / James Pope
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information as stipulated under
the UK version of the market abuse regulation no 596/2014 which is part of
English law by virtue of the European (withdrawal) act 2018, as amended. On
publication of this announcement via a regulatory information service, this
information is considered to be in the public domain.
About Microsaic (www.microsaic.com)
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering
chip-based mass spectrometry equipment. Having invested £30m over the last 20
years before and after the IPO, Microsaic has a robust patent portfolio in
cutting-edge technology purpose built for "Industry 4.0" which enables
analytical detection and characterisation at the point-of-need, whether within
a human health environment, conventional laboratory setting, or within a
bioprocessing facility for continuous mass spectrometer detection and
monitoring of data at any step in the process workflow.
Microsaic's products and systems are commercially available through global
markets via a network of regional and local partners, targeting its core
laboratory, manufacturing, and point-of-need applications.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACSFLMITMTATBPJ